Mark Cuban defends his disruption status

Experts in healthcare and the pharmaceutical industry have questioned Mark Cuban’s ability to puncture high-priced medicines. In a 90-minute fireside chat with one of his critics, Mr. Cuban said his company has “truly changed the game.”

Read the full post on Becker's Hospital Review | Healthcare News & Analysis